The United States Food and Drug Administration recently stated all testosterone medications need to include a general warning about the risk of blood clots in veins. This labeling change was prompted in part by reports of these types of clots.
The FDA is also currently re-evaluating the safety of testosterone with a emphasis on the risk of stroke, heart attack and death. According to the FDA, the labeling expansion is not related to the ongoing investigation.
If you or a loved one had a stroke, pulmonary embolism, blood clot or heart attack while taking testosterone, please call our experienced testosterone attorneys at (888) 606-5297 for a free consultationa about your potential testosterone lawsuit.